MRNA
MRNA
US · Stock · NYSE/NASDAQ
$54.07
Pre-Market · NYSE/NASDAQ
AIQ Score (0-100)
33
/100
BEARISH
Smart Score (1-10)
2 /10
Momentum23
Value34
Quality33
Risk50
Sentiment60
Current market regime: Defensive

In a Defensive regime, MRNA's AIQ Score of 33/100 with Quality base of 33/100 and fading Momentum at 23/100 (Δ-34) suggests caution. Reduce position size or hold. Confirm reversal before re-entering.

Signal conflict detected

Sentiment (60/100) leads while Momentum (23/100) lags. This cross-factor spread creates entry timing uncertainty. Wait for the lagging factor to begin recovering before adding aggressively.

Why MRNA scores 33 — top signal drivers
Golden Cross Active
high-impact trend signal at 30.69% supporting upside conditions: Golden Cross Active.
bullish+76.00%
ATR Expansion - Breakout Mode
medium-impact volatility signal at 7.54% worth monitoring: ATR Expansion - Breakout Mode.
neutral+68.00%
Keltner Channel Breakdown
medium-impact volatility signal at 54.07 warning of downside pressure: Keltner Channel Breakdown.
caution+68.00%
RSI Oversold - Potential Bounce
medium-impact momentum signal at 14.2 supporting upside conditions: RSI Oversold - Potential Bounce.
bullish+68.00%
MACD Bearish Crossover
low-impact momentum signal at -0.7711 warning of downside pressure: MACD Bearish Crossover.
bearish+61.00%
Healthcare·sector move·Market context unavailable.

Quick Stats

Market Cap
P/E Ratio
P/B Ratio
Dividend Yield
Beta
Volume
52W High
52W Low
Evidence Receipts + Persistence
AIQ score today
33/100
Defensive
30-day Avg AIQ
45/100
+12 vs today — trending down
Days with AIQ ≥ 60 (last 60)
0 of 60 trading days
Strongest driver
Sentiment 60/100 — constructive
Binding constraint
Momentum 23/100 — weak
7-day momentum Δ
-34 pts — fading
AIQ Score Change Narrative

MRNA's 7-day signal profile is softening with AIQ change of -9.0 points and momentum delta of -34.0. Trend delta is -9.00, which helps frame whether the current move is accelerating or fading.

Snapshot: Sat, 25 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.

AIQ Δ7d: -9.0Momentum Δ7d: -34.0Value Δ7d: 0.0Quality Δ7d: 0.0Risk Δ7d: 0.0Trend Δ7d: -9.00
Weekly Score Historymethodology →
DateAIQMomValQualResilience
2026-07-253323343350
2026-07-184257343350
2026-07-114466343350
2026-07-044985343350
2026-06-274883343350
Recent News
See all news
Sentiment —
No recent news found for MRNA

MRNA (MRNA) Stock Analysis

Snapshot summary of AIQ score, trend, and risk context.

MRNA (MRNA) has an AIQ Score of 33/100 in a Defensive regime as of Jul 25, 2026. Sentiment is strongest at 60/100. Momentum is weakest at 23/100. The main conflict is that sentiment leads at 60/100 while momentum lags at 23/100.

MRNA (MRNA) carries an AIQ Score of 33 out of 100, placing it in a bearish signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.

Beta is 1.35, implying roughly 35% higher sensitivity than a broad market baseline.

In the latest weekly profile, AIQ has moved -9.0 points over the last 7 days, momentum delta is -34.0, trend delta is -9.00, risk delta is 0.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.

Evidence LayerPublic Evidence
Regime ContextMRNA is in a Defensive AIQ regime with score 33/100.
Signal ConflictThe primary conflict is that sentiment leads at 60/100 while momentum lags at 23/100.
Factor EvidenceMomentum 23/100 · Value 34/100 · Quality 33/100 · Risk 50/100 · Sentiment 60/100
PersistenceMRNA has scored AIQ 60+ in 0 of the last 60 daily snapshots. 30-day avg: 45/100. 60-day avg: 43/100.
ChecklistStatusEvidence
Factor strengthWaitSentiment is the strongest factor at 60/100.
TimingFailMomentum is 23/100 with 7-day delta -34.0.
Regime fitFailMRNA is in a Defensive regime at 33/100.
Risk controlWaitRisk factor is 50/100 with beta of 1.35 indicates above-market sensitivity.
ConflictWaitCurrent conflict: sentiment leads at 60/100 while momentum lags at 23/100.
AIQ 60+ snapshots: 0/60
30-snapshot avg: 45/100
60-snapshot avg: 43/100
What Changed Recently (MRNA)

MRNA's 7-day signal profile is softening with AIQ change of -9.0 points and momentum delta of -34.0. Trend delta is -9.00, which helps frame whether the current move is accelerating or fading.

Signal snapshot as of Sat, 25 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.

AIQ Δ7d: -9.0
Momentum Δ7d: -34.0
Value Δ7d: 0.0
Quality Δ7d: 0.0
Risk Δ7d: 0.0
Trend Δ7d: -9.00
MetricCurrent
AIQ Score33/100
Price$54.07
Beta1.35

MRNA vs Large Cap Pharma Peers

MRNA ranks 5 of 5 in this peer set. Full sector ranking →
Compare Stocks
SymbolAIQSmartVerdict
NVO6810Neutral
OGN629Neutral
REGN619Neutral
PFE578Neutral
MRNA332Bearish

Portfolio Implication

MRNA currently shows elevated downside sensitivity. Beta is currently unavailable, so position sizing should be reviewed with scenario analysis.

MRNA Stock FAQ

What does the MRNA AIQ Score mean?

AIQ Score summarizes multiple factors for MRNA, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.

How often is MRNA data updated?

MRNA quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.

Should I compare MRNA with an index before investing?

Yes. Comparing MRNA versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.

Where can I review deeper MRNA fundamentals, technicals, and risk?

Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.

How the AIQ Score Is Built

Methodology, factor weights, and how to interpret score history

Read the methodology →

Loading MRNA...

© 2026 AlgoVestIQTermsPrivacyRisk Disclosure

Informational only, not investment advice. Investing involves risk, including loss of principal.